Analyst Consensus ?
ConsensusBuy57 ratings
Bullish4680.7%
Neutral1119.3%
Bearish00.0%
Take-Two Interactive Software, Inc. · TTWO · FY2026 Q4 · Calendar Q2 2026
Take-Two Closes FY26 With Record Bookings, Bets Big on GTA VI Launch
Take-Two Interactive closed fiscal 2026 with record net bookings of $6.72 billion, above the prior guidance range of $6.65-$6.7 billion. EPS of $0.80 beat the $0.563 consensus by 42%, and revenue of $1.58 billion topped estimates by 2.2%. The company set FY27 guidance at $8-8.2 billion in net bookings — roughly 20% growth — with the November 19 GTA VI launch as the primary catalyst. Despite the beat, shares fell 4.4% in the next session on 3.75x baseline volume, with the abnormal move at -4.8% versus a flat benchmark. The decline is consistent with concerns raised on the call about a $300 million OpEx increase, potential cannibalization of GTA Online by GTA VI, and an FY27 assumption of flat-to-declining mobile spend. Shares subsequently drifted 6.6% higher, partially retracing the initial reaction.
Reported After market closeNASDAQTechnology
$45.75B market cap
100quality score
Company context
Snapshot as of publicationEstablished in 1993 and headquartered in New York, New York, Take-Two Interactive Software, Inc. is a global leader in the development, publishing, and marketing of interactive entertainment experiences for consumers worldwide. The company's extensive catalog is primarily distributed under its prominent labels: Rockstar Games, 2K, Private Division, and T2 Mobile Games. Rockstar Games is renowned for its action-adventure titles, including iconic franchises like Grand Theft Auto, Red Dead Redemption, Max Payne, and Midnight Club, alongside other fan favorites such as LA Noire, Bully, and Manhunt. The 2K label covers a broad spectrum of genres, offering popular series in shooter (Borderlands), action (BioShock, Mafia), role-playing, strategy (Sid Meier's Civilization, XCOM series), sports, and family/casual categories.…
Earnings scorecard
Reported versus consensus
Reported EPS
$0.80
Consensus $1
EPS surprise
+42.1%
Reported versus consensus
Reported revenue
$1.58B
Consensus $1.55B
Revenue surprise
+2.2%
Reported versus consensus
Earnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$235.03Current
$105Low
$226.56Average
$313High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Aug 24, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Wells Fargo | Overweight | Overweight | Maintain | Aug 10, 2026 |
| Wedbush | Outperform | Outperform | Maintain | Aug 10, 2026 |
| Roth Capital | Buy | Buy | Maintain | Aug 10, 2026 |
| Oppenheimer | Outperform | Outperform | Maintain | Aug 10, 2026 |
| DA Davidson | Buy | Buy | Maintain | Aug 10, 2026 |
| BTIG | Buy | Buy | Maintain | Aug 10, 2026 |
| Baird | Outperform | Outperform | Maintain | Aug 10, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | Jun 25, 2026 |
| B of A Securities | Buy | Buy | Maintain | Jun 23, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Jun 2, 2026 |
| UBS | Buy | Buy | Maintain | Jan 28, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Jan 13, 2026 |
| Jefferies | Buy | Buy | Maintain | Nov 3, 2025 |
| Benchmark | Buy | Buy | Maintain | Oct 16, 2025 |
| Raymond James | Outperform | Outperform | Maintain | Aug 8, 2025 |
| JP Morgan | Overweight | Overweight | Maintain | Aug 8, 2025 |
| Citigroup | Buy | Buy | Maintain | Jul 23, 2025 |
| Ascendiant Capital | Buy | Buy | Maintain | Mar 3, 2025 |
| MoffettNathanson | Neutral | Neutral | Maintain | Feb 7, 2025 |
| Goldman Sachs | Buy | Buy | Maintain | Feb 7, 2025 |
| Stifel | Buy | Buy | Maintain | Jan 21, 2025 |
| TD Cowen | Buy | Buy | Maintain | Nov 22, 2024 |
| Roth MKM | Buy | Buy | Maintain | Nov 19, 2024 |
| HSBC | Buy | Hold | Upgrade | Aug 12, 2024 |
| Deutsche Bank | Buy | Hold | Upgrade | Nov 14, 2023 |
| Truist Securities | Buy | Buy | Maintain | Oct 31, 2023 |
| Barclays | Overweight | Overweight | Maintain | Aug 10, 2023 |
| Credit Suisse | Neutral | Neutral | Maintain | Aug 9, 2023 |
| Exane BNP Paribas | Neutral | Outperform | Downgrade | Apr 12, 2023 |
| DZ Bank | Hold | Buy | Downgrade | Feb 14, 2023 |
| Keybanc | Overweight | Overweight | Maintain | Feb 7, 2023 |
| MKM Partners | Buy | Buy | Maintain | Nov 8, 2022 |
| Cowen & Co. | Outperform | Outperform | Maintain | Nov 8, 2022 |
| Bernstein | Outperform | Outperform | Maintain | Apr 22, 2022 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | Jul 23, 2020 |
| Stephens & Co. | Equal Weight | Equal Weight | Maintain | May 21, 2020 |
| Nomura Instinet | Neutral | Neutral | Maintain | May 21, 2020 |
| Nomura | Neutral | Neutral | Maintain | May 21, 2020 |
| CFRA | Buy | Buy | Maintain | Mar 25, 2020 |
| Stifel Nicolaus | Buy | Buy | Maintain | Mar 2, 2020 |
| Bank of America | Buy | Buy | Maintain | Aug 21, 2019 |
| Buckingham Research | Buy | Buy | Maintain | May 14, 2019 |
| Gabelli & Co. | Buy | Buy | Maintain | Jan 16, 2019 |
| Hilliard Lyons | Neutral | Underperform | Upgrade | Feb 9, 2018 |
| BTIG Research | Buy | Buy | Maintain | Dec 18, 2017 |
| Buckingham | Buy | Buy | Maintain | Nov 8, 2017 |
| Macquarie | Outperform | Outperform | Maintain | Feb 4, 2016 |
| PiperJaffray | Overweight | Overweight | Maintain | Aug 11, 2015 |
| Brean Capital | Buy | Buy | Maintain | Jul 28, 2015 |
| Mizuho | Buy | Buy | Maintain | Jun 26, 2015 |
| Sterne Agee CRT | Buy | Neutral | Upgrade | May 19, 2015 |
| Sterne Agee | Buy | Neutral | Upgrade | May 19, 2015 |
| Leerink Swann | Perform | Market Perform | Maintain | Sep 2, 2014 |
| CRT Capital | Hold | Hold | Maintain | Jan 17, 2014 |
| Pacific Crest | Perform | Sector Perform | Maintain | Sep 11, 2013 |
| National Alliance Securities | Buy | Buy | Maintain | Aug 2, 2012 |
| National Alliance | Buy | Buy | Maintain | Aug 2, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $235.02. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Goldman Sachs | Analyst unavailable | $285 | $252.15 | +21.3% | Aug 10, 2026 |
| Robert W. Baird | Colin Sebastian | $270 | $246.5 | +14.9% | Aug 10, 2026 |
| Oppenheimer | Martin Yang | $280 | $246.5 | +19.1% | Aug 10, 2026 |
| BTIG | Clark Lampen | $313 | $246.5 | +33.2% | Aug 10, 2026 |
| Wells Fargo | Alec Brondolo | $300 | $246.5 | +27.6% | Aug 10, 2026 |
| Roth Capital | Analyst unavailable | $300 | $246.5 | +27.6% | Aug 7, 2026 |
| Raymond James | Andrew Marok | $300 | $233.94 | +27.6% | Aug 6, 2026 |
| Wells Fargo | Alec Brondolo | $289 | $258.41 | +23.0% | Jul 7, 2026 |
| BMO Capital | Brian Pitz | $285 | $235.47 | +21.3% | Jun 25, 2026 |
| BTIG | Analyst unavailable | $290 | $242.64 | +23.4% | Jun 24, 2026 |
| Piper Sandler | Analyst unavailable | $280 | $226.98 | +19.1% | Jun 2, 2026 |
| Wells Fargo | Analyst unavailable | $287 | $238.08 | +22.1% | May 22, 2026 |
| Wedbush | Alicia Reese | $300 | $218.68 | +27.6% | Mar 3, 2026 |
| Raymond James | Strong Buy | $285 | $205.03 | +21.3% | Feb 10, 2026 |
| BMO Capital | Analyst unavailable | $280 | $204.2 | +19.1% | Feb 4, 2026 |
| Wells Fargo | Analyst unavailable | $301 | $212.17 | +28.1% | Feb 4, 2026 |
| UBS | Analyst unavailable | $300 | $247.33 | +27.6% | Jan 28, 2026 |
| Morgan Stanley | Matthew Cost | $280 | $249.83 | +19.1% | Jan 13, 2026 |
| Wells Fargo | Analyst unavailable | $288 | $256.67 | +22.5% | Jan 8, 2026 |
| Arete Research | Analyst unavailable | $284 | $246.03 | +20.8% | Dec 1, 2025 |
| UBS | Christopher Schoell | $292 | $231.92 | +24.2% | Nov 7, 2025 |
| Jefferies | James Heaney | $300 | $256.37 | +27.6% | Nov 3, 2025 |
| Roth Capital | Analyst unavailable | $295 | $259.23 | +25.5% | Oct 17, 2025 |
| D.A. Davidson | Analyst unavailable | $300 | $258.07 | +27.6% | Oct 9, 2025 |
| Wells Fargo | Alec Brondolo | $277 | $256.98 | +17.9% | Oct 7, 2025 |
| Redburn Partners | Hamilton Faber | $260 | $232.68 | +10.6% | Aug 13, 2025 |
| BMO Capital | Brian Pitz | $252 | $217.37 | +7.2% | Aug 8, 2025 |
| Raymond James | Andrew Marok | $250 | $226.74 | +6.4% | May 16, 2025 |
| D.A. Davidson | Wyatt Swanson | $270 | $226.74 | +14.9% | May 16, 2025 |
| Stifel Nicolaus | Drew Crum | $191 | $158.04 | -18.7% | Sep 5, 2024 |
| HSBC | Mohammed Khallouf | $179 | $147.29 | -23.8% | Aug 12, 2024 |
| Goldman Sachs | Eric Sheridan | $186 | $144.82 | -20.9% | Aug 9, 2024 |
| Jefferies | James Heaney | $185 | $148.83 | -21.3% | Jul 11, 2024 |
| Deutsche Bank | Bryan Kraft | $190 | $155.37 | -19.2% | Jun 18, 2024 |
| J.P. Morgan | Cory A Carpenter | $200 | $158.51 | -14.9% | Jun 11, 2024 |
| Robert W. Baird | Colin Sebastian | $172 | $147.84 | -26.8% | May 20, 2024 |
| HSBC | Mohammed Khallouf | $154 | $151 | -34.5% | May 17, 2024 |
| Goldman Sachs | Eric Sheridan | $170 | $146.08 | -27.7% | May 17, 2024 |
| Jefferies | Andrew Uerkwitz | $195 | $148.49 | -17.0% | Apr 1, 2024 |
| Wedbush | Nick McKay | $190 | $155.09 | -19.2% | Feb 9, 2024 |
| Deutsche Bank | Benjamin Soff | $175 | $153.4 | -25.5% | Nov 14, 2023 |
| Oppenheimer | Martin Yang | $170 | $145.73 | -27.7% | Nov 9, 2023 |
| Raymond James | Andrew Marok | $170 | $145.71 | -27.7% | Oct 11, 2023 |
| Truist Financial | Matthew Thornton | $158 | $150.26 | -32.8% | Jul 11, 2023 |
| Morgan Stanley | Matthew Cost | $145 | $125.02 | -38.3% | May 18, 2023 |
| Credit Suisse | Stephen Ju | $127 | $122.57 | -46.0% | May 17, 2023 |
| Roth Capital | Analyst unavailable | $130 | $114.65 | -44.7% | Feb 7, 2023 |
| J.P. Morgan | Analyst unavailable | $140 | $109.74 | -40.4% | Feb 7, 2023 |
| Wedbush | Analyst unavailable | $130 | $105.56 | -44.7% | Feb 7, 2023 |
| Credit Suisse | Analyst unavailable | $129 | $111.47 | -45.1% | Feb 3, 2023 |
| Citigroup | Analyst unavailable | $105 | $100.79 | -55.3% | Dec 9, 2022 |
| Stifel Nicolaus | Drew Cum | $161 | $108.4 | -31.5% | Nov 8, 2022 |
| Truist Financial | Matthew Thornton | $157 | $118.63 | -33.2% | Sep 5, 2022 |
| Barclays | Mario Lu Lu | $175 | $123.04 | -25.5% | Aug 30, 2022 |
| Truist Financial | Matthew Thornton | $162 | $127.39 | -31.1% | Aug 4, 2022 |
| Credit Suisse | Stephen Ju | $139 | $130.65 | -40.9% | Jul 27, 2022 |
| UBS | John Hodulik | $143 | $127.04 | -39.2% | Jul 6, 2022 |
| Goldman Sachs | Eric Sheridan | $136 | $129.23 | -42.1% | Jun 9, 2022 |
| Stifel Nicolaus | Drew Crum | $200 | $123.08 | -14.9% | May 17, 2022 |
| Credit Suisse | Stephen Ju | $182 | $123.08 | -22.6% | May 17, 2022 |
| Bernstein | Matti Littunen | $173 | $136.41 | -26.4% | Apr 22, 2022 |
| KeyBanc | Tyler Parker | $190 | $141.31 | -19.2% | Apr 10, 2022 |
| Benchmark Co. | Mike Hickey | $200 | $153.49 | -14.9% | Mar 13, 2022 |
| MKM Partners | Eric Handler | $200 | $158.01 | -14.9% | Mar 5, 2022 |
| Credit Suisse | Stephen Ju | $210 | $172.2 | -10.6% | Feb 8, 2022 |
| Robert W. Baird | Colin Sebastian | $210 | $175.1 | -10.6% | Feb 7, 2022 |
| BNP Paribas | Nicolas Langlet | $215 | $163.36 | -8.5% | Jan 19, 2022 |
| Morgan Stanley | Brian Nowak | $215 | $148.42 | -8.5% | Jan 11, 2022 |
| MoffettNathanson | Clay Griffin | $170 | $148.42 | -27.7% | Jan 11, 2022 |
| Ascendiant | Edward Woo | $191 | $142.99 | -18.7% | Jan 10, 2022 |
| Oppenheimer | Martin Yang | $215 | $192.91 | -8.5% | Nov 4, 2021 |
| Barclays | Mario Lu | $220 | $192.91 | -6.4% | Nov 4, 2021 |
| DZ BANK AG | Manuel Muhl | $210 | $158.75 | -10.6% | Aug 4, 2021 |
| Cowen & Co. | Doug Creutz | $229 | $159.86 | -2.6% | Aug 3, 2021 |
| Goldman Sachs | Eric Sheridan | $185 | $185.08 | -21.3% | May 20, 2021 |
Track every rating change on TTWO the moment it posts. Free to start.
Start freeMarket reaction
event-close to next-session close
Stock move
-4.4%
Event window
SPY move
+0.4%
Same window
Abnormal move
-4.8%
Stock minus SPY
Volume
3.7×
Versus trailing sessions
Subsequent drift
+6.6%
Up to 20 sessions
TTWOSPY benchmark
Follow TTWO with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeTranscript intelligence
What changed
FY2026 net bookings reached $6.72 billion, above the raised guidance range of $6.65-$6.7 billion. FY27 guidance set at $8-8.2 billion in net bookings, approximately 20% above FY26. Operating cash flow of $624 million generated in fiscal 2026. Operating expenses rose roughly $300 million, prompting analyst questions on the marketing vs G&A vs R&D breakdown. First use of licensed AI to produce zero-cost marketing ads; Rockstar launched a Mission Creator tool for user-generated content. Capex outlook increased to approximately $200 million for game technology and office build-outs.
Guidance delta
Prior quarter: FY2026 bookings outlook raised to $6.65-$6.7 billion. Current quarter: FY2026 actual bookings of $6.72 billion exceeded that range. FY27 guidance introduced at $8-8.2 billion, a ~20% increase. Guidance sentiment remained raised; management tone remained confident.
Key takeaways
- FY2026 net bookings of $6.72 billion exceeded guidance, with $624 million in operating cash flow.
- GTA VI launch on November 19 is the centerpiece of FY27 growth, supporting $8-8.2 billion in projected net bookings.
- Mobile titles like Toon Blast and Match Factory continue to grow, though FY27 assumes flat to modestly declining mobile spend.
- AI tools are being deployed to cut marketing costs, including the first zero-cost AI-generated ads.
- Capital allocation prioritizes organic growth, selective acquisitions, and opportunistic share buybacks.
Management priorities
- Launch Grand Theft Auto VI on November 19, 2026.
- Ship six additional FY27 titles across mobile, sports, and platform extensions.
- Deliver content updates for NBA 2K, WWE 2K, and Red Dead Redemption.
- Invest approximately $200 million in capex for game technology and infrastructure.
- Scale AI tools across marketing and development for operational efficiency.
Sources
- Earnings call transcript and parsed analysis · 2026-05-22T00:22:08.449640+00:00
- FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
- Polygon adjusted daily market bars · 2026-07-30T01:42:03.775135+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-07-30T01:42:03.773144+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated . For educational purposes only; not investment advice.